Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 2 Interventional

nVNS, CBD, and SoC for Persistent Post-Traumatic Headache

ClinicalTrials.gov ID: NCT07624279

Public ClinicalTrials.gov record NCT07624279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes

Study identification

NCT ID
NCT07624279
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
American Society of Pain and Neuroscience, Inc.
Other
Enrollment
80 participants

Conditions and interventions

Interventions

  • Non-Invasive Vagus Nerve Stimulation Device
  • Cannabidiol Drug
  • Standard of Care Drug

Device · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2026
Primary completion
Jul 30, 2027
Completion
Jun 30, 2028
Last update posted
Jun 2, 2026

2026 – 2028

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85054
Kerlan-Jobe Orthopaedic Institute Los Angeles California 90045
International Spine, Pain & Performance Center Washington D.C. District of Columbia 20006
Florida Spine & Pain Specialists Tampa Florida 33614
University of Kansas Medical Center Kansas City Kansas 66160
Premier Pain Center Shrewsbury New Jersey 07702
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Allegheny General Hospital Pittsburgh Pennsylvania 15212

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07624279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2026 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07624279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →